Cell Growth & Differentiation, Vol 6, Issue 10 1235-1244, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells

YP Rao, DJ Buckley and AR Buckley
Department of Pharmacology and Toxicology, University of North Dakota School of Medicine, Grand Forks 58202, USA.

Several serine/threonine and tyrosine kinase signal transduction pathways have been recently linked to prolactin (PRL) action in lymphoid cells. Utilizing the lactogen-dependent, rat pre-T lymphoma cell line, Nb2-11, and the autonomous subline, Nb2-SFJCD1, studies were conducted to determine whether PRL- or interleukin-2 (IL-2)-stimulated Nb2 cell proliferation is coupled to the activation of p21ras and mitogen-activated protein (MAP) kinase. Stimulation of Nb2-11 cells, growth-arrested in the early G1 phase of the cell cycle, with PRL or IL-2 rapidly (5-10 min) provoked GTP binding to Ras, enhanced tyrosyl phosphorylation of MAP kinase, significantly increased its enzymatic activity, and caused its nuclear translocation. The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), which directly activates protein kinase C, similarly activated Ras and MAP kinase but failed to cause its nuclear translocation. Tyrosine kinase antagonism with genistein inhibited PRL-stimulated Ras and MAP kinase activation. In other experiments, Ras and MAP kinase were each found to be constitutively active in the Nb2-SFJCD1 line. The addition of PRL to these cultures enhanced the activity of these signaling proteins. Finally, the effects of PRL, IL-2, TPA, and phosphatase inhibition on Nb2-11 cell population density and [3H]thymidine uptake were compared. The addition of PRL, IL-2, and TPA significantly stimulated[3H] thymidine incorporation, while only the polypeptide growth factors augmented cell density. Phosphatase inhibition had no effect on either parameter. These results indicate that Nb2 cell proliferation is associated with the early activation of Ras and MAP kinase. Moreover, tyrosyl phosphorylation upstream of Ras activation appears to be required for its subsequent stimulation of mediators, which activate MAP kinase. Protein kinase C activation may be coupled to MAP kinase activation but is not sufficient for Nb2 cell proliferation.

This article has been cited by other articles:

				F. J. Steyn, G. M. Anderson, and D. R. Grattan Hormonal Regulation of Suppressors of Cytokine Signaling (SOCS) Messenger Ribonucleic Acid in the Arcuate Nucleus during Late Pregnancy Endocrinology, June 1, 2008; 149(6): 3206 - 3214. [Abstract] [Full Text] [PDF]

				N. Hattori, H. Nomoto, H. Fukumitsu, S. Mishima, and S. Furukawa AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase Evid. Based Complement. Altern. Med., October 29, 2007; (2007) nem146v1. [Abstract] [Full Text] [PDF]

				M. J. LeBaron, T. J. Ahonen, M. T. Nevalainen, and H. Rui In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays Endocrinology, March 1, 2007; 148(3): 989 - 1008. [Abstract] [Full Text] [PDF]

				M. E C Amaral, D. A Cunha, G. F Anhe, M. Ueno, E. M Carneiro, L. A Velloso, S. Bordin, and A. C Boschero Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy J. Endocrinol., December 1, 2004; 183(3): 469 - 476. [Abstract] [Full Text] [PDF]

				T. J. Ahonen, P. L. Harkonen, H. Rui, and M. T. Nevalainen PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro Endocrinology, January 1, 2002; 143(1): 228 - 238. [Abstract] [Full Text] [PDF]

				J. B. Kline, D. J. Moore, and C. V. Clevenger Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site Mol. Endocrinol., May 1, 2001; 15(5): 832 - 841. [Abstract] [Full Text]

				K. M. McAveney, M. L. Book, P. Ling, J. Chebath, and L.-y. Yu-Lee Association of 2',5'-Oligoadenylate Synthetase with the Prolactin (PRL) Receptor: Alteration in PRL-Inducible Stat1 (Signal Transducer and Activator of Transcription 1) Signaling to the IRF-1 (Interferon-Regulatory Factor 1) Promoter Mol. Endocrinol., February 1, 2000; 14(2): 295 - 306. [Abstract] [Full Text]

				K. E. Borg, M. Zhang, D. Hegge, R. L. Stephen, D. J. Buckley, N. S. Magnuson, and A. R. Buckley Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements Endocrinology, December 1, 1999; 140(12): 5659 - 5668. [Abstract] [Full Text]

				H. Yamashita, J. Xu, R. A. Erwin, A. C. Larner, and H. Rui A Lymphoma Growth Inhibitor Blocks Some but Not All Prolactin-stimulated Signaling Pathways J. Biol. Chem., May 21, 1999; 274(21): 14699 - 14705. [Abstract] [Full Text] [PDF]

				C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]

				L. Tseng and H. H. Zhu Progestin, Estrogen, and Insulin-like Growth Factor-I Stimulate the Prolactin Receptor mRNA in Human Endometrial Stromal Cells Reproductive Sciences, May 1, 1998; 5(3): 149 - 155. [Abstract] [PDF]

				M. Wartmann, N. Cella, P. Hofer, B. Groner, X. Liu, L. Hennighausen, and N. E. Hynes Lactogenic Hormone Activation of Stat5 and Transcription of the beta -Casein Gene in Mammary Epithelial Cells Is Independent of p42 ERK2 Mitogen-activated Protein Kinase Activity J. Biol. Chem., December 13, 1996; 271(50): 31863 - 31868. [Abstract] [Full Text] [PDF]